Potential Drug Interaction Between Warfarin, COVID-19 Treatment Reported
The patients, a 71-year-old male and a 62 year-old-male, both on long-term warfarin therapy, presented to the emergency department with symptoms of COVID-19.
The patients, a 71-year-old male and a 62 year-old-male, both on long-term warfarin therapy, presented to the emergency department with symptoms of COVID-19.
The approval was based on data from 3 clinical studies that assessed the antihypertensive effect of valsartan in 290 children 1 to less than 6 years of age.
The recalled products were distributed from November 13, 2020 through April 9, 2021 to in-store and e-commerce retailers.
Most common pain locations were back and hip, knee, or foot; physical therapy and massage most often used for management
Nation is close to meeting President Biden’s goal of 200 million shots in arms by his 100th day in office
Total and measles-containing vaccines declined markedly in all children but recovered in those aged 0 to 23 months
After adjustment for maternal sociodemographic, prepregnancy, pregnancy, and perinatal covariates, no link found with autism spectrum disorders
Results from 2 studies show statistically significant improvement in scalp hair regrowth with baricitinib, a JAK inhibitor.
The 7-vaccine series provides immunization against diphtheria, pertussis, tetanus, poliovirus, measles, mumps, rubella, hepatitis b, Haemophilus influenze type b, varicella, and pneumococcal infections.
The patient developed a generalized maculopapular rash approximately 3 hours after receiving warfarin.
Please login or register first to view this content.